Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa--fifth investigation. A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Medical Research Councils.
D000293:Adolescent; D000328:Adult; D000351:Africa, Eastern; D000368:Aged; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002986:Clinical Trials as Topic; D003875:Drug Eruptions / Q000209:etiology; D004352:Drug Resistance, Microbial; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage* / Q000652:urine; D008875:Middle Aged; D011859:Radiography; D013183:Sputum / Q000382:microbiology; D013307:Streptomycin / Q000008:administration & dosage / Q000009:adverse effects; D013828:Thioacetazone / Q000008:administration & dosage* / Q000009:adverse effects; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology; D014717:Vertigo / Q000139:chemically induced
D013828:Thioacetazone; D007538:Isoniazid; D013307:Streptomycin